ArticleViruses2022

SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron.

Syed Faraz Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.